Oaktree Acquisition Corp. III Life Sciences OACC
NASDAQ OACC
$10.82 +0.07 (+0.65%)
At close: Aug 20, 2026 · 4:00 PM EDT

Oaktree Acquisition Corp. III Life Sciences (OACC) Income towards Parent Company (2025 - 2026)

Oaktree Acquisition Corp. III Life Sciences' (OACC) quarterly Income towards Parent Company came in at $1.4 million in Q1 2026, down 15.96% YoY from $1.7 million in Q1 2025, and down 22.07% on a QoQ basis from $1.8 million in Q4 2025.

Oaktree Acquisition Corp. III Life Sciences (OACC) Income towards Parent Company (2025 - 2026) Analysis & Trends

Oaktree Acquisition Corp. III Life Sciences (OACC) has 2 years of Income towards Parent Company data on file, last reported at $1.4 million in Q1 2026.

  • Quarterly Income towards Parent Company fell 15.96% year-over-year to $1.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.0 million (changed N/A YoY) and the FY2025 annual result came in at $7.3 million, up 489.27% from the prior year.
  • Income towards Parent Company retreated to $1.4 million in Q1 2026, from $1.8 million in the prior quarter.
  • In the past five years, Income towards Parent Company ranged from a high of $2.0 million in Q3 2025 to a low of $1.4 million in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oxley Bridge Acquisition 585.76 Mn 585.76 Mn -
2 Launch Two Acquisition 557.86 Mn 557.86 Mn -
3 Drugs Made In America Acquisition 507.00 Mn 507.00 Mn -
4 Cantor Equity Partners IV 468.00 Mn 468.00 Mn -
5 GP-Act III Acquisition 401.06 Mn 401.06 Mn -
6 Aldel Financial 397.49 Mn 397.49 Mn -
7 Republic Digital Acquisition 389.25 Mn 388.51 Mn -
8 Gores Holdings X 385.06 Mn 384.87 Mn -
9 Agriculture & Natural Solutions Acquisition 377.29 Mn 377.04 Mn -
10 Oaktree Acquisition Corp. III Life Sciences 206.39 Mn 206.39 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2026 1.60 Mn
Mar 31, 2026 1.39 Mn
Dec 31, 2025 1.79 Mn
Sep 30, 2025 1.97 Mn
Jun 30, 2025 1.87 Mn
Mar 31, 2025 1.66 Mn